Mission

Cancer is a disease of many faces. A major challenge with this disease is therapy failure, which can arise from intrinsic tumour-cell properties or from interactions within the tumour microenvironment. Through the collaborative use of omics profiling, imaging, molecular biology, pharmacology, and in silico approaches, we seek to (1) define the mechanisms by which tumours and their microenvironment respond to therapies, (2) design therapeutic strategies that maximise tumour kill with minimal host toxicity.